| Leo Rodriguez, MD | |
|
2481 Morgan Ave, Corpus Christi, TX 78405-1883 | |
| (361) 882-6080 | |
| (361) 882-6089 |
| Full Name | Leo Rodriguez |
|---|---|
| Gender | Male |
| Speciality | Obstetrics/gynecology |
| Experience | 29 Years |
| Location | 2481 Morgan Ave, Corpus Christi, Texas |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1174527006 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207V00000X | Obstetrics & Gynecology | J3377 (Texas) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Obhg Texas Holdings Pa | 3577713072 | 87 |
News Archive
Despite recent advances in diagnosis and treatment, the prognosis of patients with biliary tract cancer is still poor. Elucidating the biological characteristics of these carcinomas has become necessary to improve the prognosis of patients and to devise better treatment strategies. A recent study report that invasive front dominant expression of LNγ2 and LNβ3 and active MMP7 play a key role in the progression of biliary tract cancer.
The 5α-reductase inhibitor, dutasteride, delays the clinical progression of prostate cancer in patients with prostate-specific antigen levels that have failed to reduce adequately following radical therapy for localized disease, report researchers.
Senate Republican leaders Thursday released their revised bill to "repeal and replace" the Affordable Care Act, but they acknowledged that furious days of negotiation have not yet secured the 50 votes necessary to pass the measure over unanimous Democratic objections.
Getting the COVID-19 vaccine — especially the second shot — can produce minor side effects such as aches and fever that tend to go away after a day or two. Adding to the list, a small study from the University of Arizona found that people may find it slightly challenging to exercise after getting a two-dose coronavirus vaccine.
pSivida Corp., a leader in the development of sustained release back of the eye drug delivery systems for difficult-to-treat conditions, today announced that its licensee, Alimera Sciences has submitted a Marketing Authorization Application (MAA) to the Medicines and Healthcare Products Regulatory Agency (MHRA) in the United Kingdom (UK) for Iluvien®.
› Verified 3 days ago
| Entity Name | Coastal Bend Womens Center |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1891812483 PECOS PAC ID: 7911991914 Enrollment ID: O20040413000431 |
News Archive
Despite recent advances in diagnosis and treatment, the prognosis of patients with biliary tract cancer is still poor. Elucidating the biological characteristics of these carcinomas has become necessary to improve the prognosis of patients and to devise better treatment strategies. A recent study report that invasive front dominant expression of LNγ2 and LNβ3 and active MMP7 play a key role in the progression of biliary tract cancer.
The 5α-reductase inhibitor, dutasteride, delays the clinical progression of prostate cancer in patients with prostate-specific antigen levels that have failed to reduce adequately following radical therapy for localized disease, report researchers.
Senate Republican leaders Thursday released their revised bill to "repeal and replace" the Affordable Care Act, but they acknowledged that furious days of negotiation have not yet secured the 50 votes necessary to pass the measure over unanimous Democratic objections.
Getting the COVID-19 vaccine — especially the second shot — can produce minor side effects such as aches and fever that tend to go away after a day or two. Adding to the list, a small study from the University of Arizona found that people may find it slightly challenging to exercise after getting a two-dose coronavirus vaccine.
pSivida Corp., a leader in the development of sustained release back of the eye drug delivery systems for difficult-to-treat conditions, today announced that its licensee, Alimera Sciences has submitted a Marketing Authorization Application (MAA) to the Medicines and Healthcare Products Regulatory Agency (MHRA) in the United Kingdom (UK) for Iluvien®.
› Verified 3 days ago
| Entity Name | Lone Star Ob/gyn Associates, P.a. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1063441921 PECOS PAC ID: 5294720132 Enrollment ID: O20040419001336 |
News Archive
Despite recent advances in diagnosis and treatment, the prognosis of patients with biliary tract cancer is still poor. Elucidating the biological characteristics of these carcinomas has become necessary to improve the prognosis of patients and to devise better treatment strategies. A recent study report that invasive front dominant expression of LNγ2 and LNβ3 and active MMP7 play a key role in the progression of biliary tract cancer.
The 5α-reductase inhibitor, dutasteride, delays the clinical progression of prostate cancer in patients with prostate-specific antigen levels that have failed to reduce adequately following radical therapy for localized disease, report researchers.
Senate Republican leaders Thursday released their revised bill to "repeal and replace" the Affordable Care Act, but they acknowledged that furious days of negotiation have not yet secured the 50 votes necessary to pass the measure over unanimous Democratic objections.
Getting the COVID-19 vaccine — especially the second shot — can produce minor side effects such as aches and fever that tend to go away after a day or two. Adding to the list, a small study from the University of Arizona found that people may find it slightly challenging to exercise after getting a two-dose coronavirus vaccine.
pSivida Corp., a leader in the development of sustained release back of the eye drug delivery systems for difficult-to-treat conditions, today announced that its licensee, Alimera Sciences has submitted a Marketing Authorization Application (MAA) to the Medicines and Healthcare Products Regulatory Agency (MHRA) in the United Kingdom (UK) for Iluvien®.
› Verified 3 days ago
| Entity Name | Obhg Texas Holdings Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1083917769 PECOS PAC ID: 3577713072 Enrollment ID: O20121018000279 |
News Archive
Despite recent advances in diagnosis and treatment, the prognosis of patients with biliary tract cancer is still poor. Elucidating the biological characteristics of these carcinomas has become necessary to improve the prognosis of patients and to devise better treatment strategies. A recent study report that invasive front dominant expression of LNγ2 and LNβ3 and active MMP7 play a key role in the progression of biliary tract cancer.
The 5α-reductase inhibitor, dutasteride, delays the clinical progression of prostate cancer in patients with prostate-specific antigen levels that have failed to reduce adequately following radical therapy for localized disease, report researchers.
Senate Republican leaders Thursday released their revised bill to "repeal and replace" the Affordable Care Act, but they acknowledged that furious days of negotiation have not yet secured the 50 votes necessary to pass the measure over unanimous Democratic objections.
Getting the COVID-19 vaccine — especially the second shot — can produce minor side effects such as aches and fever that tend to go away after a day or two. Adding to the list, a small study from the University of Arizona found that people may find it slightly challenging to exercise after getting a two-dose coronavirus vaccine.
pSivida Corp., a leader in the development of sustained release back of the eye drug delivery systems for difficult-to-treat conditions, today announced that its licensee, Alimera Sciences has submitted a Marketing Authorization Application (MAA) to the Medicines and Healthcare Products Regulatory Agency (MHRA) in the United Kingdom (UK) for Iluvien®.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Leo Rodriguez, MD 7121 S Spid Dr, Ste 200, Corpus Christi, TX 78412-4940 Ph: (361) 993-6000 | Leo Rodriguez, MD 2481 Morgan Ave, Corpus Christi, TX 78405-1883 Ph: (361) 882-6080 |
News Archive
Despite recent advances in diagnosis and treatment, the prognosis of patients with biliary tract cancer is still poor. Elucidating the biological characteristics of these carcinomas has become necessary to improve the prognosis of patients and to devise better treatment strategies. A recent study report that invasive front dominant expression of LNγ2 and LNβ3 and active MMP7 play a key role in the progression of biliary tract cancer.
The 5α-reductase inhibitor, dutasteride, delays the clinical progression of prostate cancer in patients with prostate-specific antigen levels that have failed to reduce adequately following radical therapy for localized disease, report researchers.
Senate Republican leaders Thursday released their revised bill to "repeal and replace" the Affordable Care Act, but they acknowledged that furious days of negotiation have not yet secured the 50 votes necessary to pass the measure over unanimous Democratic objections.
Getting the COVID-19 vaccine — especially the second shot — can produce minor side effects such as aches and fever that tend to go away after a day or two. Adding to the list, a small study from the University of Arizona found that people may find it slightly challenging to exercise after getting a two-dose coronavirus vaccine.
pSivida Corp., a leader in the development of sustained release back of the eye drug delivery systems for difficult-to-treat conditions, today announced that its licensee, Alimera Sciences has submitted a Marketing Authorization Application (MAA) to the Medicines and Healthcare Products Regulatory Agency (MHRA) in the United Kingdom (UK) for Iluvien®.
› Verified 3 days ago
Sultana Alamin Khimani, MD Obstetrics & Gynecology Medicare: May Accept Medicare Assignments Practice Location: 5920 Saratoga Blvd, Suite 570, Corpus Christi, TX 78414 Phone: 361-985-8100 Fax: 361-985-8131 | |
Danielle Alicia Inman, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 7121 S Padre Island Dr, Suite 302, Corpus Christi, TX 78412 Phone: 361-851-5000 Fax: 361-851-8053 | |
Dr. Jeffery Blaine Itkin, M.D. Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 5920 Saratoga Boulevard, Suite 540, Corpus Christi, TX 78414 Phone: 361-883-6030 Fax: 361-883-6442 | |
Mrs. Leighanne Glazener, MD Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 7121 S Padre Island Dr, Suite 302, Corpus Christi, TX 78412 Phone: 361-851-5000 Fax: 361-851-8053 | |
Christine L Canterbury, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 7121 Spid, Suite 302, Corpus Christi, TX 78412 Phone: 361-851-5000 Fax: 361-851-0590 | |
Juan A Villarreal, MD Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 13725 Northwest Blvd, Suite #110, Corpus Christi, TX 78410 Phone: 361-387-7177 Fax: 361-387-8355 | |
Romulo Corrada, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 7121 S Spid Dr, Ste 200, Corpus Christi, TX 78412 Phone: 361-993-6000 Fax: 361-993-3676 |